SCHEMBL15715540

SCHEMBL15715540

COc1ccccc1[P@](=O)(CF)c1ccccc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.69
▸ MEN1 O00255 2/20 0.69
▸ HTT P42858 3/20 0.57
▸ L3MBTL1 Q9Y468 1/20 0.57
▸ POLB P06746 2/20 0.44
▸ HIF1A Q16665 1/20 0.43
▸ ALDH1A1 P00352 4/20 0.41
▸ LMNA P02545 2/20 0.41
▸ RECQL P46063 1/20 0.41
▸ CA2 P00918 2/20 0.41
▸ MAPT P10636 2/20 0.39
▸ GAA P10253 1/20 0.39
▸ ALPG P10696 1/20 0.39
▸ ALOX12 P18054 1/20 0.39
▸ NPY1R P25929 1/20 0.39
▸ NPY2R P49146 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ CA12 O43570 1/20 0.39
▸ CA1 P00915 1/20 0.39
▸ CA4 P22748 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29396406 0.86 KMT2A (0.73) KMT2AMEN1HTTL3MBTL1POLB
SCHEMBL24308948 0.86 KMT2A (0.79) KMT2AMEN1HTTL3MBTL1POLB
SCHEMBL3807805 0.86 KMT2A (0.73) KMT2AMEN1HTTL3MBTL1POLB
SCHEMBL28685764 0.86 KMT2A (0.73) KMT2AMEN1HTTL3MBTL1POLB
SCHEMBL15715568 0.85 MEN1 (0.56) KMT2AMEN1HTTL3MBTL1POLB
SCHEMBL23658968 0.80 KMT2A (0.64) KMT2AMEN1HTTL3MBTL1POLB
SCHEMBL23658897 0.80 KMT2A (0.64) KMT2AMEN1HTTL3MBTL1POLB
SCHEMBL15715690 0.79 MEN1 (0.50) KMT2AMEN1HTTL3MBTL1POLB
SCHEMBL6828371 0.77 KMT2A (0.61) KMT2AMEN1HTTL3MBTL1POLB
SCHEMBL23658965 0.77 KMT2A (0.60) KMT2AMEN1HTTL3MBTL1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2920189-B1 PROCESS FOR MAKING NOVEL CHIRAL PHOSPHORUS LIGANDS BOEHRINGER INGELHEIM INT (DE) 2017-08-02 — — EP disclosed
US-8816112-B2 Process for making novel chiral phosphorus ligands BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-08-26 — — US disclosed
WO-2014078491-A1 PROCESS FOR MAKING NOVEL CHIRAL PHOSPHORUS LIGANDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-05-22 — — WO disclosed
US-20140135506-A1 PROCESS FOR MAKING NOVEL CHIRAL PHOSPHORUS LIGANDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-05-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140135506-A1 PROCESS FOR MAKING NOVEL CHIRAL PHOSPHORUS LIGANDS PHOSPHO1, INPP5B, PLCG2 KMT2A 3508/4885MEN1 1250/4885HTT 4612/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback